31 July 2023
31 July 2023
Reata is developing therapeutics for treating serious neurologic diseases, one of which is SKYCLARYS.
Sanders’s proposed bill could be another hit on the profitability of US drugs following the Inflation Reduction Act of August 2022.
Alexion will obtain access to a number of new adeno-associated virus capsids.
The tablets were recalled because of out-of-specification test results at the 12-month stability time point.
As several economies deal with inflation, there has been a reduction in deals involving contract manufacturing organisations.
Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.
Each week, Pharmaceutical Technology’s journalists explore movements in job postings that shed light on hiring trends in our sector.
The NDA has been submitted based on the data from the Phase III clinical study.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
